Singapore National Eye Centre
Quick facts
Marketed products
Phase 3 pipeline
- Travatan/ Timolol/Azopt · Ophthalmology
Travatan/Timolol/Azopt is a combination of a prostaglandin analog and a beta-blocker used to lower intraocular pressure in glaucoma patients.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Singapore National Eye Centre
What are Singapore National Eye Centre's marketed drugs?
Top marketed products include 5 Fluorouracil with hyaluronic acid.
What is Singapore National Eye Centre's pipeline?
Singapore National Eye Centre has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Travatan/ Timolol/Azopt.